Tatva Chintan Pharma Chem was incorporated on June 12, 1996. The company is a pecialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents, phase transfer catalysts, electrolyte salts for super capacitor batteriesand pharmaceutical and agrochemical intermediates and other specialty chemicals
| Bidding Dates |
|---|
| 16 Jul 2021 - 20 Jul 2021 |
| Subscription |
|---|
| 180.36x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹14,079 | 1 | 13 | 13 | 4.6 M | ₹1073 - ₹1083 | 79.17 % | ₹4953.8 M - ₹5000.0 M | RHP DOC |
Tatva Chintan Pharma IPO SUBSCRIPTION STATUS
20 Jul '21Tatva Chintan Pharma IPO overall subscription rate was 180.36 times the total available shares
Tatva Chintan Pharma IPO retail subscription rate was 35.35 times in the retail segment
Tatva Chintan Pharma IPO non-institutional investor subscription rate was 512.22 times in the non-institutional investor category
Tatva Chintan Pharma IPO Qualified Institutional Bidder subscription rate was 185.23 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
20 Jul 2021 (Day 3) | 35.35x | 512.22x | 185.23x |
19 Jul 2021 (Day 2) | 23.74x | 12.21x | 1.97x |
16 Jul 2021 (Day 1) | 8.24x | 1.14x | 0.5x |
Tatva Chintan Pharma IPO SUBSCRIPTION STATUS DETAILS
Tatva Chintan Pharma had 4.6 M shares on offer
Tatva Chintan Pharma IPO offer price was in the range ₹1073 - ₹1083
Tatva Chintan Pharma IPO minimum Investment was ₹14079
Tatva Chintan Pharma IPO issue size was ₹ 4953.8 M - ₹ 5000.0 M
Tatva Chintan Pharma had a minimum lot size of 13 Shares per application
Tatva Chintan Pharma NUMBER OF SHARES ON OFFER
Tatva Chintan Pharma IPO IMPORTANT DATES
| Issue Open Date | 16 Jul 2021 |
| Issue close Date | 20 Jul 2021 |
| Allotment Date | 26 Jul 2021 |
| Refund Date | 27 Jul 2021 |
| Demat Account Credit Date | 28 Jul 2021 |
| Listing Date | 29 Jul 2021 |
| Listing on Exchange(s) | NSE and BSE |
| Tatva Chintan Pharma Allotment Status | Exchange |
Tatva Chintan Pharma IPO subscription opened on 16 Jul 2021, and closed on 20 Jul 2021
IPO allotment for Tatva Chintan Pharma was finalized on Monday, 26 Jul 2021
IPO listing for Tatva Chintan Pharma was on NSE and BSE on Thursday, 29 Jul 2021
Tatva Chintan Pharma IPO LISTING GAINS
| Issue Price (adjusted) | 1083.0 |
| Listing Open Price | 2111.8 |
| Listing Close Price | 2310.3 |
| Listing Gain% | 95.0% |
| Current Gain% | 58.7% |
Tatva Chintan Pharma Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tatva Chintan Pharma Chem Ltd. | 1718.8 | 3809.7 | 78.2 | 0.1 | 7.2 | 5.4 | 4.2 | 509.4 | 32.3 | 42.1 | 636.1 | 22 | 618.2 |
| Pidilite Industries Ltd. | 1660 | 168953.2 | 63.8 | 3 | 11 | 22.6 | 15.9 | 14867 | 11.1 | 2448.9 | 17.9 | 26 | 21.4 |
| SRF Ltd. | 2615 | 77515.1 | 35.9 | 0.7 | 4.6 | 13.1 | 7.6 | 15893.6 | 7.2 | 1835.2 | 46.7 | 72.9 | 51.1 |
| Gujarat Fluorochemicals Ltd. | 4518.1 | 49631.3 | 85.9 | 14.7 | 9.9 | 7.3 | 4.9 | 5038 | 3.8 | 578 | 5.8 | 52.6 | 5.9 |
| Himadri Speciality Chemical Ltd. | 752.6 | 37975.8 | 47.5 | 1.6 | 7.6 | 16 | 11.9 | 4832 | 3.6 | 751.3 | 35.2 | 15.8 | 30 |
| Aether Industries Ltd. | 1591.6 | 21122.5 | 89.8 | 2.6 | 17.3 | 8.9 | 6.8 | 1181.1 | 34.2 | 219.5 | 38.5 | 17.7 | 34 |
Tatva Chintan Pharma INFORMATION ON IPO ISSUE
About Tatva Chintan Pharma
Tatva Chintan Pharma Chem was incorporated on June 12, 1996. The company is a pecialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents, phase transfer catalysts, electrolyte salts for super capacitor batteriesand pharmaceutical and agrochemical intermediates and other specialty chemicals
Object of the Issue
1. Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
2. Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
3. To meet general corporate purposes.
Tatva Chintan Pharma - PROMOTERS
| Name |
|---|
| Ajaykumar Mansukhlal Patel |
| Chintan Nitinkumar Shah |
| Snehkar Rasiklal Somani |
Tatva Chintan Pharma Book Running Lead Managers
ICICI Securities Limited
tatvachintan.ipo@icicisecurities.com
JM Financial Limited
tatvachintan.ipo@jmfl.com
Tatva Chintan Pharma Registrar to the Offer
Link Intime India Private Limited
tatva.ipo@linkintime.co.in
Tatva Chintan Pharma Strengths
Leading manufacturer
Leading manufacturer of structure directing agents and phase transfer catalyst
Product portfolio
The company has a diversified product portfolio
Global presence
Global market presence with a customer base across industries
Strategically located
Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
Experienced team
Experienced promoters and managers team
Financial performance
The company has a strong financial performance track record
Tatva Chintan Pharma Risks
Dependent on limited suppliers
The company depends on a limited number of suppliers for certain raw materials
Dependent on limited customers
The company derives a significant portion of its revenue from a few customers
IPO FAQs
This IPO consists of an offer for sale of up to Rs 275.0 crore, of 2,539,243 shares. It also consists of a fresh issue of Rs 225.0 crore.
The promoters of the company are Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah and Snehkar Rasiklal Somani.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 1073.0 - 1083.0.
The IPO application opens on Jul 16, 2021 and closes on Jul 20, 2021.
The minimum lot size for the IPO is 13. The maximum lot size for the IPO is 182.
For all category investors, the minimum application amount for this IPO is Rs. 14,079.0, the maximum value for this IPO is Rs 197,106.0.
This IPO will be allotted on Jul 26, 2021.
The refund will be credited to your account on Jul 27, 2021.
The allotted shares will be credited to your demat on Jul 28, 2021.
Tatva Chintan Pharma Chem Ltd.’s shares listed on the stock exchanges on Jul 29, 2021.